Confined or spread disease-Spread to regional lymph nodes Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread to regional lymph nodes Posts on Medivizor

Olaparib for treating breast cancer that has spread

Posted by on Mar 5, 2019 in Breast cancer | 0 comments

In a nutshell This study determined whether treating breast cancer that has spread (metastatic) with olaparib (Lynparza) resulted in better outcomes and fewer side effects compared to chemotherapy. The study found that treatment with olaparib led to similar survival outcomes compared to chemotherapy.  Some background There are...

Read More

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Posted by on Nov 11, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to see how well two medications worked in treating advanced triple negative breast cancer, atezolizumab (Tecentriq) and nab-paclitaxcel (Abraxane).  The study found that using these two medications together improved survival in these patients. Some background Triple-negative breast cancer (TNBC) is breast cancer...

Read More

Surgery to remove the main tumor in patients with breast cancer that has spread

Posted by on Oct 18, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if removing the main tumor in women with cancer that has spread to other organs leads to greater survival than not removing the main tumor. The study found that the patients who had the surgery survived 47% longer than patients without the surgery. Some background Breast cancer can sometimes be caught quite...

Read More

Nivolumab treatment is associated with an improved survival in advanced melanoma

Posted by on Oct 16, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the effect of nivolumab (Opdivo) in patients with progressive melanoma after ipilimumab (Yervoy) treatment. Researchers suggested that nivolumab treatment is associated with better response compared with chemotherapy. Some background Recent new therapies, such as immunotherapy, have changed the treatment of...

Read More

How safe and effective is chemotherapy given through the limb in elderly melanoma patients?

Posted by on Sep 13, 2017 in Melanoma | 0 comments

In a nutshell This study looked at the safety and effectiveness of isolated limb infusion in elderly patients with melanoma of the skin on a limb (arm/leg) that could not be surgically removed. The study found isolated limb infusion to be safe and effective in elderly patients.  Some background lsolated limb perfusion (ILP) is a method of...

Read More

Fulvestrant: an option for estrogen-receptor positive breast cancer that has spread

Posted by on Aug 5, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to compare fulvestrant (Faslodex) to other standard endocrine agents in patients with advanced hormone sensitive breast cancer. This study concluded that fulvestrant was as effective as the available standard endocrine agents.  Some background Advanced hormone sensitive breast cancer (BC) is cancer that has...

Read More

Is abemaciclib combined with fulvestrant effective in women with HR positive advanced breast cancer?

Posted by on Jul 15, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to compare the effectiveness of the combination of fulvestrant (Faslodex) and abemaciclib to fulvestrant alone in patients with advanced breast cancer. This study concluded that the combination of fulvestrant and abemaciclib had improved outcomes for patients when compared to fulvestrant alone.  Some background...

Read More

The role of dexamethasone mouthwash in preventing everolimus-related stomatitis in women with breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the use of dexamethasone (Ozurdex) mouthwash for preventing stomatitis in patients with breast cancer(BC).  The use of dexamethasone oral solution was found to significantly reduce the incidence and severity of stomatitis. Some background Everolimus (Afinitor) and exemestane (Aromasin) are mTOR inhibitors...

Read More